Saul Tzipori

Q: What Schools Are Affiliated With Saul Tzipori

Saul Tzipori is affiliated with the following schools: University of Queensland, Tufts University, University of Minnesota, Makerere University, University of Melbourne, Texas A&M University, Tulane University, Monash University

Saul Tzipori's AcademicInfluence.com Rankings

Saul Tzipori

Biology

#8477

World Rank

#11560

Historical Rank

Microbiology

#431

World Rank

#486

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Saul Tzipori Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Saul Tzipori is an American microbiologist, currently the Agnes Varis University Chair and Distinguished Professor at Tufts University. He is a Fellow of the Royal College of Veterinary Surgeons.

(See a Problem?)

Saul Tzipori's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum (2004) (903)
The Biology of (2000) (863)
The genome of Cryptosporidium hominis (2004) (505)
Evidence for the shikimate pathway in apicomplexan parasites (1998) (460)
Cryptosporidiosis in animals and humans. (1983) (372)
The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. (1993) (362)
Cryptosporidiosis: biology, pathogenesis and disease. (2002) (294)
Prevalence of Enterocytozoon bieneusi in Swine: an 18-Month Survey at a Slaughterhouse in Massachusetts (2002) (253)
The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection (1995) (232)
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets (1987) (231)
Cryptosporidium hominis: experimental challenge of healthy adults. (2006) (229)
Cryptosporidiosis in Perspective (1988) (213)
Cryptosporidium parvum in children with diarrhea in Mulago Hospital, Kampala, Uganda. (2003) (200)
The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. (1986) (197)
Cryptosporidiosis and microsporidiosis in ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. (2005) (191)
Natural history and biology of Cryptosporidium parvum. (1998) (187)
A hundred-year retrospective on cryptosporidiosis. (2008) (180)
Integration of Word Meaning and World Knowledge in Language Comprehension (178)
Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. (1986) (177)
Experimental cryptosporidiosis in laboratory mice (1982) (166)
Molecular Cloning and Expression of a Gene EncodingCryptosporidium parvum Glycoproteins gp40 and gp15 (2000) (161)
Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors (1989) (160)
Prevalence of Cryptosporidium Antibodies in 10 Animal Species (1981) (152)
Self-Regulation of Candida albicans Population Size during GI Colonization (2007) (152)
Cryptosporidium: evidence for a single-species genus. (1980) (151)
Cryptosporidiosis in hospital patients with gastroenteritis. (1983) (145)
Multilocus Genotypic Analysis of Cryptosporidium parvum Isolates from Different Hosts and Geographical Origins (1998) (144)
The shikimate pathway and its branches in apicomplexan parasites. (2002) (143)
A pig model of the human gastrointestinal tract (2013) (143)
Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model (1992) (138)
Hafnia alvei, a probable cause of diarrhea in humans (1991) (137)
Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. (1990) (136)
Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge. (2008) (131)
Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection. (1985) (124)
Efficacy of Nitazoxanide againstCryptosporidium parvum in Cell Culture and in Animal Models (1998) (124)
Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium (2008) (123)
Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat (1996) (121)
Genomic Survey of the Non-Cultivatable Opportunistic Human Pathogen, Enterocytozoon bieneusi (2009) (118)
Mediation of Cryptosporidium parvumInfection In Vitro by Mucin-Like Glycoproteins Defined by a Neutralizing Monoclonal Antibody (2000) (118)
Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. (1998) (117)
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility. (2007) (116)
Experimental cryptosporidiosis in calves: clinical manifestations and pathological findings (1983) (116)
Intestinal parasites in patients with diarrhea and human immunodeficiency virus infection in Zimbabwe. (1999) (115)
Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome (2004) (114)
Human Stx2-Specific Monoclonal Antibodies Prevent Systemic Complications of Escherichia coli O157:H7 Infection (2002) (114)
The Reduced Genome of the Parasitic Microsporidian Enterocytozoon bieneusi Lacks Genes for Core Carbon Metabolism (2010) (114)
Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. (1994) (113)
Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double‐blind, controlled clinical trial (1995) (112)
Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection (1997) (112)
CHRONIC CRYPTOSPORIDIAL DIARRHOEA AND HYPERIMMUNE COW COLOSTRUM (1987) (107)
Animal propagation and genomic survey of a genotype 1 isolate of Cryptosporidium parvum. (2000) (105)
Enterocytozoon bieneusi among children with diarrhea attending Mulago Hospital in Uganda. (2002) (104)
Piglet models of acute or chronic Clostridium difficile illness. (2010) (102)
Cryptosporidiosis: laboratory investigations and chemotherapy. (1998) (101)
Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease. (2013) (101)
Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death (1994) (100)
Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice. (2002) (98)
The relative importance of enteric pathogens affecting neonates of domestic animals. (1985) (98)
Invasive Lesions Containing Filamentous Forms Produced by a Candida albicans Mutant That Is Defective in Filamentous Growth in Culture (1999) (96)
Identification of an Enterocytozoon bieneusi-like microsporidian parasite in simian-immunodeficiency-virus-inoculated macaques with hepatobiliary disease. (1997) (96)
Continuous culture of Cryptosporidium parvum using hollow fiber technology. (2016) (92)
A new restriction fragment length polymorphism from Cryptosporidium parvum identifies genetically heterogeneous parasite populations and genotypic changes following transmission from bovine to human hosts (1997) (90)
Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. (2000) (90)
The Evolution of Respiratory Cryptosporidiosis: Evidence for Transmission by Inhalation (2014) (89)
Genetic Analysis of a Cryptosporidium parvum Human Genotype 1 Isolate Passaged through Different Host Species (2002) (87)
Detection and Genotyping of Oocysts of Cryptosporidium parvum by Real-Time PCR and Melting Curve Analysis (2002) (87)
The aetiology and diagnosis of calf diarrhoea (1981) (85)
Characterization of Cryptosporidium meleagridis of Human Origin Passaged through Different Host Species (2003) (85)
Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. (2012) (85)
Hepatic intranuclear particles in patients with non-A, non-B hepatitis. (1980) (82)
The Gamma Interferon Gene Knockout Mouse: a Highly Sensitive Model for Evaluation of Therapeutic Agents againstCryptosporidium parvum (1998) (82)
Human Antibody against Shiga Toxin 2 Administered to Piglets after the Onset of Diarrhea Due to Escherichia coli O157:H7 Prevents Fatal Systemic Complications (2005) (81)
Identification of genotypically mixed Cryptosporidium parvum populations in humans and calves. (2003) (79)
An outbreak of calf diarrhoea attributed to cryptosporidial infection (1980) (79)
A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2 (2013) (78)
A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model (2012) (78)
A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection (2012) (77)
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent target. (2004) (74)
Separation of Cryptosporidium species oocysts from feces by using a percoll discontinuous density gradient (1986) (74)
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors. (2006) (73)
Inferences about the Global Population Structures of Cryptosporidium parvum and Cryptosporidium hominis (2008) (71)
Diarrhea in lambs experimentally infected with Cryptosporidium isolated from calves. (1981) (71)
Extensive Polymorphism in Cryptosporidium parvumIdentified by Multilocus Microsatellite Analysis (2000) (71)
Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission. (2010) (70)
Enteric adenovirus infection among infants with diarrhea in rural Bangladesh (1993) (70)
Cryptosporidium parvum Infection of Human Intestinal Xenografts in SCID Mice Induces Production of Human Tumor Necrosis Factor Alpha and Interleukin-8 (1998) (68)
Experimental infection of piglets with Cryptosporidium (1981) (67)
Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. (1988) (67)
Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution (1991) (67)
Transmission and establishment of a persistent infection of Enterocytozoon bieneusi, derived from a human with AIDS, in simian immunodeficiency virus-infected rhesus monkeys. (1997) (67)
Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province. (2007) (67)
The pathogenesis of Yersinia enterocolitica infection in gnotobiotic piglets. (1985) (66)
Experimental evidence for genetic recombination in the opportunistic pathogen Cryptosporidium parvum. (2002) (63)
Studies in gnotobiotic piglets on non-O157:H7 Escherichia coli serotypes isolated from patients with hemorrhagic colitis. (1988) (62)
Parameters affecting polymerase chain reaction detection of waterborne Cryptosporidium parvum oocysts (1997) (62)
Diarrhea due to Cryptosporidium infection in artificially reared lambs (1981) (61)
Paromomycin and Geneticin Inhibit IntracellularCryptosporidium parvum without Trafficking through the Host Cell Cytoplasm: Implications for Drug Delivery (1998) (61)
Increased adherence and actin pedestal formation by dam‐deficient enterohaemorrhagic Escherichia coli O157:H7 (2007) (60)
Production and Characterization of Protective Human Antibodies against Shiga Toxin 1 (2002) (60)
Intestinal Lesions Associated with Disseminated Candidiasis in an Experimental Animal Model (2000) (59)
Hyperimmune bovine colostrum for treatment of GI infections (2013) (59)
Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex. (2008) (59)
The biology of Cryptosporidium. (2000) (58)
Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. (2003) (58)
Sequence Polymorphism in the β-Tubulin Gene Reveals Heterogeneous and Variable Population Structures inCryptosporidium parvum (1998) (57)
Subtype Analysis of Cryptosporidium Isolates From Children in Uganda (2006) (56)
Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection. (2009) (56)
parvum Cryptosporidium Complete Genome Sequence of the Apicomplexan , (2012) (56)
Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection. (2016) (54)
Cryptosporidium meleagridis: infectivity in healthy adult volunteers. (2011) (54)
The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. (1982) (54)
Intestinal Lesions in Specific-Pathogen-Free Lambs Associated with a Cryptosporidium from Calves with Diarrhea (1982) (53)
β-Tubulin mRNA as a Marker ofCryptosporidium parvum Oocyst Viability (1999) (52)
Development and application of genetic probes for detection of Enterocytozoon bieneusi in formalin-fixed stools and in intestinal biopsy specimens from infected patients (1997) (52)
Detection of astrovirus in the faeces of red deer (1981) (52)
Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages. (2009) (51)
Transmission and Serial Propagation ofEnterocytozoon bieneusi from Humans and Rhesus Macaques in Gnotobiotic Piglets (1998) (51)
Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro (1994) (50)
Enterocolitis in piglets caused by Cryptosporidium sp. purified from calf faeces. (1982) (50)
Streptococcus durans: an unexpected enteropathogen of foals. (1984) (50)
HOST CELL APOPTOSIS IMPAIRS CRYPTOSPORIDIUM PARVUM DEVELOPMENT IN VITRO (2000) (50)
Patterns of Genome Evolution among the Microsporidian Parasites Encephalitozoon cuniculi, Antonospora locustae and Enterocytozoon bieneusi (2007) (49)
In vitro and in vivo pathogenicity of Plesiomonas shigelloides (1987) (49)
Stx2-Specific Human Monoclonal Antibodies Protect Mice against Lethal Infection with Escherichia coli Expressing Stx2 Variants (2003) (49)
Intracellular Neutralization of Shiga Toxin 2 by an A Subunit-Specific Human Monoclonal Antibody (2008) (49)
EspFU, a type III‐translocated effector of actin assembly, fosters epithelial association and late‐stage intestinal colonization by E. coli O157:H7 (2008) (48)
Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum. (1995) (47)
Localization of Persistent Enterocytozoon bieneusiInfection in Normal Rhesus Macaques (Macaca mulatta) to the Hepatobiliary Tree (1998) (47)
An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins. (2009) (46)
Experimental infection of lambs with Cryptosporidium isolated from a human patient with diarrhoea. (1982) (45)
Efficient Serum Clearance of Botulinum Neurotoxin Achieved Using a Pool of Small Antitoxin Binding Agents (2009) (44)
Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection. (2014) (44)
Development of a Bacillus subtilis-Based Rotavirus Vaccine (2010) (43)
Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double‐blind, randomized, controlled trial (2001) (43)
A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1. (2010) (43)
Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. (1995) (43)
Clinical manifestations of diarrhea in calves infected with rotavirus and enterotoxigenic Escherichia coli (1981) (43)
The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins (2009) (42)
Silk Fibroin Microneedles for Transdermal Vaccine Delivery. (2017) (42)
Failure to Propagate Cryptosporidium spp. in Cell-Free Culture (2006) (42)
Diarrhea in lambs: experimental infections with enterotoxigenic Escherichia coli, rotavirus, and Cryptosporidium sp (1981) (42)
Diarrhoea in goat kids attributed to cryptosporidium infection (1982) (41)
Factors contributing to postweaning diarrhoea in a large intensive piggery. (1980) (41)
Portable continuous flow centrifugation and method 1623 for monitoring of waterborne protozoa from large volumes of various water matrices (2006) (41)
The clinical response of gnotobiotic calves, pigs and lambs to inoculation with human, calf, pig and foal rotavirus isolates. (1980) (41)
Vomiting and diarrhea associated with cryptosporidial infection. (1980) (40)
Escherichia coli and rotavirus infections in four-week-old gnotobiotic piglets fed milk or dry food. (1980) (40)
Diarrhea in Young Red Deer Associated with Infection with Cryptosporidium (1981) (40)
Sequence polymorphism in the beta-tubulin gene reveals heterogeneous and variable population structures in Cryptosporidium parvum. (1998) (40)
Water-borne Cryptosporidium: a perspective from the USA. (1996) (39)
In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism (2011) (39)
Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium difficile Toxin A (2009) (39)
Cryptosporidium muris: infectivity and illness in healthy adult volunteers. (2015) (38)
Comparison of two label-free global quantitation methods, APEX and 2D gel electrophoresis, applied to the Shigella dysenteriae proteome (2009) (38)
An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. (1997) (37)
beta-tubulin mRNA as a marker of Cryptosporidium parvum oocyst viability. (1999) (37)
Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice. (2011) (37)
Antibody-Based Protection of Gnotobiotic Piglets Infected with Escherichia coli O157:H7 against Systemic Complications Associated with Shiga Toxin 2 (1999) (37)
A comparative study of specific gene probes and standard bioassays to identify diarrhoeagenic Escherichia coli in paediatric patients with diarrhoea in Bangladesh. (1992) (36)
THE UTILIZATION OF SODIUM TAUROCHOLATE IN EXCYSTATION OF CRYPTOSPORIDIUM PARVUM AND INFECTION OF TISSUE CULTURE (2001) (35)
Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity. (2010) (34)
Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum. (2012) (34)
Tegumental Phosphodiesterase SmNPP-5 Is a Virulence Factor for Schistosomes (2011) (33)
Propagation of human rotavirus in young dogs (1978) (33)
Ingestible Osmotic Pill for In Vivo Sampling of Gut Microbiomes (2019) (33)
Microsporidiosis and Malnutrition in Children with Persistent Diarrhea, Uganda (2009) (32)
Evaluation of a portable differential continuous flow centrifuge for concentration of Cryptosporidium oocysts and Giardia cysts from water (1999) (32)
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection (2016) (32)
Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. (1998) (31)
ISOLATION OF ROTAVIRUS FROM FOALS WITH DIARRHOEA (1978) (30)
DNA probe analysis of diarrhoeagenic Escherichia coli: detection of EAF-positive isolates of traditional enteropathogenic E. coli serotypes among Bangladeshi paediatric diarrhoea patients. (1992) (30)
Enteroaggregative Escherichia coli infections in Bangladeshi children: clinical and microbiological features. (1991) (30)
Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. (1994) (30)
Rapid Displacement of Cryptosporidium parvum Type 1 by Type 2 in Mixed Infections in Piglets (2003) (30)
Allele- and Tir-Independent Functions of Intimin in Diverse Animal Infection Models (2012) (30)
Bile Acids Enhance Invasiveness of Cryptosporidium spp. into Cultured Cells (2006) (29)
Heterologous protection against rotavirus-induced disease in gnotobiotic piglets (1986) (29)
Isolation of a rotavirus from deer (1976) (29)
Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C. (2010) (27)
Analysis of the β‐Tubulin Genes from Enterocytozoon bieneusi Isolates from a Human and Rhesus Macaque (2007) (27)
Studies on vaccines against bovine ephemeral fever. (1973) (27)
Diarrhoea in piglets inoculated with rotavirus. (1978) (27)
Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis (2018) (26)
Gel electrophoresis of rotavirus RNA derived from six different animal species. (1979) (25)
Enteritis in foals induced by rotavirus and enterotoxigenic Escherichia coli. (1982) (25)
Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets. (2012) (25)
Enhanced Actin Pedestal Formation by Enterohemorrhagic Escherichia coli O157:H7 Adapted to the Mammalian Host (2011) (24)
Monoclonal Antibodies against Enterocytozoon bieneusi of Human Origin (2005) (24)
Adenovirus Vector Expressing Stx1/Stx2-Neutralizing Agent Protects Piglets Infected with Escherichia coli O157:H7 against Fatal Systemic Intoxication (2014) (23)
Evaluation of Fab and F(ab′)2 Fragments and Isotype Variants of a Recombinant Human Monoclonal Antibody against Shiga Toxin 2 (2010) (23)
MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile (2012) (22)
Effects of Surotomycin on Clostridium difficile Viability and Toxin Production In Vitro (2015) (22)
Attachment of Cryptosporidium parvumSporozoites to Human Intestinal Epithelial Cells (1998) (22)
Inexpensive techniques for the production and maintenance of gnotobiotic piglets, calves and lambs. (1980) (21)
Variability among Cryptosporidium parvum genotype 1 and 2 immunodominant surface glycoproteins (2002) (21)
Haemorrhagic necrotising enteritis in foals associated with Clostridium perfringens. (1985) (21)
Transcriptome analysis of pig intestinal cell monolayers infected with Cryptosporidium parvum asexual stages (2018) (21)
Production and Characterization of Monoclonal Antibodies against Enterocytozoon bieneusi Purified from Rhesus Macaques (2005) (21)
CHARACTERIZATION OF SUBTILASE PROTEASE IN CRYPTOSPORIDIUM PARVUM AND C. HOMINIS (2007) (21)
Cryptosporidium: notes on epidemiology and pathogenesis. (1985) (21)
Purification of Enterocytozoon bieneusi from Stools and Production of Specific Antibodies (2005) (20)
ENTERIC CORONAVIRUS‐LIKE PARTICLES IN SHEEP (1978) (20)
The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof. (2014) (20)
Piperazine-Derivative MMV665917: An Effective Drug in the Diarrheic Piglet Model of Cryptosporidium hominis. (2019) (20)
Characterizing the Escherichia coli O157:H7 Proteome Including Protein Associations with Higher Order Assemblies (2011) (19)
Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets (2013) (19)
Sensitivity and Specificity of a Monoclonal Antibody-Based Fluorescence Assay for Detecting Enterocytozoon bieneusi Spores in Feces of Simian Immunodeficiency Virus-Infected Macaques (2005) (19)
The association of haemagglutination and adhesion with lipopolysaccharide of Shigella dysenteriae serotype 1. (1991) (18)
An ELISA for the detection of localized adherent classic enteropathogenic Escherichia coli serogroups. (1991) (18)
Involvement of host calpain in the invasion of Cryptosporidium parvum. (2011) (18)
Quantitative evaluation of Enterocytozoon bieneusi infection in simian immunodeficiency virus‐infected rhesus monkeys (2003) (18)
In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2 (2010) (18)
A one-year survey of rotavirus strains from three locations in Bangladesh (2005) (18)
Expectoration of Cryptosporidium Parasites in Sputum of Human Immunodeficiency Virus–Positive and –Negative Adults (2018) (18)
Intestinal changes associated with rotavirus and enterotoxigenic Escherichia coli infection in calves (1983) (18)
Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. (1998) (18)
A DNA oligonucleotide microarray for detecting human astrovirus serotypes. (2008) (17)
A cell culture vaccine against bovine ephemeral fever. (1978) (17)
Immune responses to Shigella dysenteriae 1 and Shigella flexneri lipopolysaccharide and polysaccharide antigens in Bangladeshi patients with shigellosis (1993) (17)
Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. (2010) (17)
Enterocytozoon bieneusi infection in patients without evidence of immunosuppression: two cases from Zimbabwe found to have positive stools by PCR (2000) (17)
Interaction of Cryptosporidium parvum with mouse dendritic cells leads to their activation and parasite transportation to mesenteric lymph nodes. (2014) (17)
Willingness to Consult a Veterinarian on Physician’s Advice for Zoonotic Diseases: A Formal Role for Veterinarians in Medicine? (2015) (17)
QUANTITATIVE TRACKING OF CRYPTOSPORIDIUM INFECTION IN CELL CULTURE WITH CFSE (2006) (17)
Development and protective efficacy of a recombinant-DNA derived fimbrial vaccine against enterotoxic colibacillosis in neonatal piglets. (1988) (16)
Frequent Occurrence of Mixed Enterocytozoon bieneusi Infections in Humans (2013) (16)
Serial Propagation of the Microsporidian Enterocytozoon bieneusi of Human Origin in Immunocompromised Rodents (2006) (16)
HUMAN ROTAVIRUS IN YOUNG DOGS (1976) (15)
Characterization of a Human Monoclonal Antibody against Shiga Toxin 2 Expressed in Chinese Hamster Ovary Cells (2005) (15)
Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination. (2015) (15)
The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis (2017) (15)
Selective Evolution of Ligands by Exponential Enrichment to Identify RNA Aptamers against Shiga Toxins (2014) (15)
The transcriptome of Cryptosporidium oocysts and intracellular stages (2019) (15)
Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection (2005) (15)
Development of Patent Infection in Immunosuppressed C57BL/6 Mice with a Single Cryptosporidium meleagridis Oocyst (2003) (14)
A study of Cryptosporidium parvum genotypes and population structure. (1998) (14)
Localized adherence and attaching-effacing properties of nonenteropathogenic serotypes of Escherichia coli (1991) (14)
Systemically Administered IgG Anti-Toxin Antibodies Protect the Colonic Mucosa during Infection with Clostridium difficile in the Piglet Model (2014) (13)
A fatal case associated with shigellosis and Vibrio fluvialis bacteremia. (1991) (13)
Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates (2016) (13)
Beneficial Effect of Oral Tigecycline Treatment on Clostridium difficile Infection in Gnotobiotic Piglets (2014) (13)
Recombinant Proteins of Cryptosporidium parvum Induce Proliferation of Mesenteric Lymph Node Cells in Infected Mice (2005) (13)
Attachment of E. coli-bearing K88 antigen to equine brush-border membranes. (1984) (13)
Introduction. Cryptosporidiosis: current trends and challenges. (2002) (13)
Abundance of Aeromonas spp. in various components of pond ecoysystems in Dhaka, Bangladesh (1992) (13)
The piglet acute diarrhea model for evaluating efficacy of treatment and control of cryptosporidiosis (2018) (13)
Immune-based treatment and prevention of Clostridium difficile infection (2014) (13)
Single-domain antibodies pinpoint potential targets within Shigella invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion (2017) (13)
Antibody Response of Healthy Adults to Recombinant Thrombospondin-Related Adhesive Protein of Cryptosporidium 1 after Experimental Exposure to Cryptosporidium Oocysts (2004) (13)
Experimental colibacillosis in gnotobiotic piglets exposed to 3 enterotoxigenic serotypes (1982) (13)
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases. (2020) (12)
Development and behaviour of a strain of bovine ephemeral fever virus with unusual host range. (1974) (12)
Cryopreservation of infectious Cryptosporidiumparvum oocysts (2018) (12)
Screening of pig intestines for K88 non-adhesive phenotype by enzyme immunoassay. (1986) (12)
Rapid detection ofShigella dysenteriae andShigella flexneri in faeces by an immunomagnetic assay with monoclonal antibodies (2005) (11)
A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters (2015) (11)
Cultivation and characterization of novel human group A rotaviruses with long RNA electropherotypes, subgroup II specificities, and serotype 2 VP7 genes (1991) (11)
Isolation and serotyping of animal rotaviruses and antigenic comparison with human rotaviruses (2005) (11)
The clinical manifestation and pathogenesis of enteritis associated with rotavirus and enterotoxigenic Escherichia coli infections in domestic animals. (1983) (11)
Zymodemes of Entamoeba histolytica in Dhaka, Bangladesh. (1990) (11)
Studies on the bacterial flora of fish which are potential pathogens for human. Virulence factors of potential human pathogen isolated. (1994) (10)
Plaque assay and characteristics of strains of bovine ephemeral fever virus in Vero cells. (1975) (10)
Therapeutic Evaluation of Polyamine Analogue Drug Candidates against Enterocytozoon bieneusi in a SCID Mouse Model (2009) (10)
Opportunistic protozoa in humans (1998) (10)
Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters (2018) (10)
Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A (2017) (10)
Colitis in sheep due to a Campylobacter‐like bacterium (1984) (9)
The isolation of bovine ephemeral fever virus in cell cultures and evidence for autointerference. (1975) (9)
Reply: Shikimate pathway in apicomplexan parasites (1999) (9)
MBX-500 Is Effective for Treatment of Clostridium difficile Infection in Gnotobiotic Piglets (2013) (9)
Cryptosporidiosis in animals and humans (1983) (9)
Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model. (2013) (9)
Postweaning diarrhoea in pigs: an interaction between change to dry food and colibacillosis (1984) (8)
Cryptosporidiosis and routine parasitological diagnosis. (1987) (8)
Genetic markers differentiate C. parvum isolates. (1994) (8)
Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection. (2011) (8)
Rapid concentration of Bacillus and Clostridium spores from large volumes of milk, using continuous flow centrifugation. (2009) (8)
Construction and Characterization of an Isogenicslt-ii Deletion Mutant of EnterohemorrhagicEscherichia coli (1998) (8)
Tu2054 SYN-004, a Clinical Stage Oral Beta-Lactamase Therapy, Protects the Intestinal Microflora from Antibiotic-Mediated Damage in Humanized Pigs (2015) (7)
M17 human neuroblastoma cell as a cell model for investigation of Botulinum Neurotoxin A activity and evaluation of BoNT/A specific antibody (2008) (7)
The roles of toxin A and toxin B in Clostridium difficile infection (2014) (7)
Erratum: Evidence for the shikimate pathway in apicomplexan parasites (1998) (7)
Identification and characterization of a new 34 kDa MORN motif-containing sporozoite surface-exposed protein, Cp-P34, unique to Cryptosporidium. (2021) (6)
Constitutive expression of small subunit ribosomal RNA transcripts in Cryptosporidium parvum oocysts and intracellular stages. (1999) (6)
Cryopreservation of Infectious Cryptosporidium parvum Oocysts (2018) (6)
Factors contributing to spontaneous Enterocytozoon bieneusi infection in simian immunodeficiency virus‐infected macaques (2006) (6)
Outbreak of keratoconjunctivitis due to Salmonella weltevreden in a guinea pig colony (1991) (6)
The susceptibility of young and newborn calves to bovine ephemeral fever virus. (1975) (5)
MyD88‐dependent pathway is essential for the innate immunity to Enterocytozoon bieneusi (2011) (5)
Corrigendum: The genome of Cryptosporidium hominis (2004) (5)
Studies on the role of virulence determinants of Yersinia enterocolitica in gnotobiotic piglets. (1987) (5)
Stx 2-Specific Human Monoclonal Antibodies Protect Mice against Lethal Infection with Escherichia coli Expressing Stx 2 Variants (2003) (5)
Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1 (2012) (5)
Paromomycin treatment against cryptosporidiosis in patients with AIDS. (1995) (4)
Ingestible Osmotic Pill for In-vivo Sampling of Gut Microbiome (2019) (4)
The effect of bovine ephemeral fever virus on the bovine foetus. (1975) (4)
The susceptibility of calves to infection with a strain of bovine ephemeral fever virus inoculated intracerebrally. (1975) (4)
An immunocompetent rat model of infection with Cryptosporidium species: Cryptosporidium hominis and Cryptosporidium parvum. (2019) (4)
Cryptosporidiosis in childhood. (1987) (4)
Molecular Characterization of Ribonucleotide Reductase from Cryptosporidium parvum (2002) (4)
Preliminary analysis of the cryptosporidium muris genome (2009) (3)
Cryptosporidium Parvum Volunteer Study: Infectivity and Immunity (2003) (3)
Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. (2000) (3)
Effect of colchicine on microtubules in Cryptosporidium parvum. (1994) (3)
Silk-based microneedle transdermal immunization with EV71 vaccines elicits potent immune responses in mice (2016) (3)
Evaluation of a probe hybridisation serotyping method for group A rotavirus. (1993) (3)
Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice (2012) (3)
Bovine ephemeral fever : virological investigations related to the production of vaccine (1974) (3)
Early neonatal diarrhoea of piglets associated with non-haemolytic enterotoxigenic Escherichia coli. (1980) (3)
Infection with anthroponotic Cryptosporidium parvum does not fully protect the host against a subsequent challenge with C. hominis. (2018) (3)
Growth of bovine cell monolayer cultures from tissue explants. (1974) (3)
Studies on attenuation of rotavirus (1989) (2)
Cryopreservation of infectious Cryptosporidium parvum oocysts achieved through vitrification using high aspect ratio specimen containers (2020) (2)
Protozoan Diseases: Cryptosporidiosis, Giardiasis, and Other Intestinal Protozoan Diseases (2017) (2)
Diarrhea DuetoCryptosporidium Infection inArtificially Reared Lambs (1981) (2)
Molecular and phenotypic analysis of Crytosporidium parvum oocysts of human and animal origin (2001) (2)
CRYPTOSPORIDIUM PARVUM AND INFECTION OF TISSUE CULTURE (2001) (1)
Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice (2012) (1)
Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917 (2021) (1)
Cryptosporidiosis in Calves: Significance within the Enteritis Syndrome and Diagnosis of Infection (1981) (1)
Diagnosis and treatment of cryptosporidiosis. (2000) (1)
Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessments (2022) (1)
Therapeutics which accelerate degradation BoNT/A LC within neurons (2008) (1)
Infectious diarrhoea in the young : strategies for control in humans and animals : proceedings of an International Seminar on Diarrhoeal Disease in South East Asia and the Western Pacific Region, Geelong, Australia, 10-15 February 1985 (1985) (1)
Annotation Cryptosporidiosis in childhood (1987) (1)
Repurposing tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively-drug resistant (XDR) Shigella spp. (2021) (1)
Human monoclonal antibodies against Cryptosporidium parvum generated by hypo-osmolar electrofusion. (1993) (1)
Crytosporidium diarrhea in aids patients treated with hyperimmune bovine colostrum (1990) (1)
Toxemia is the Cause of Systemic Disease in Piglet and Mouse Models of Clostridium difficile Infection (2011) (1)
A Strategy for rapid development and simplified production of therapeutic antitoxins tested on botulinum neurotoxin (2013) (0)
humans and gnotobiotic piglets . Escherichia coli O 157 : H 7 in Cerebral infection with (2005) (0)
Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp (2022) (0)
Selected highlights from other journals (2015) (0)
Tegumental phosphosdiesterase SmNPP-5 is a virulence factor for 1 schistosomes 2 3 (2011) (0)
Rapid vitrification strategies for preservation of protozoa (2022) (0)
of Veterinary Biotechnology; Key Laboratory of Urban Agriculture (South) Ministry of (2016) (0)
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis (2023) (0)
Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis (2022) (0)
Piglet Enteritis; Field and Laboratory Evaluation of Enteropathogens Associated with 3 Disease Entities (1981) (0)
Simultaneous infection with multiple serotypes of Shigellae in a patient. (1991) (0)
Cryopreservation of infectious Cryptosporidiumparvum oocysts (2018) (0)
Rotavirus infection detected in neonates from hospitals in urban Bangladesh (2005) (0)
Appendicectomy and yersiniosis (1983) (0)
Reliability of colony characteristics on MacConkey agar to identify Escherichia coli for epidemiological investigations. (1990) (0)
A chimeric protein (mTcd138) comprising the glucosyltransferase and domains of toxin B and the receptor binding domain of toxin A provides full protection against Clostridium difficile infection in mice (2014) (0)
InVitro andInVivoPathogenicity ofPlesiomonas shigelloides (1987) (0)
Selected highlights from other journals: Are people willing to consult a veterinarian if they are diagnosed with a zoonotic disease? (2015) (0)
Piglets Gnotobiotic Clostridium difficile Infection in MBX-500 Is Effective for Treatment of (2014) (0)
2006 Pathogen and Toxin Concentration Systems for Water Monitoring (2012) (0)
Diarrhea inRuralBangladesh: Two-Year StudyofIncidence andSerotype Distribution (1991) (0)
Mixed Diarrhoeal Infection in Calves: The Relative Importance of 2 Interacting Enteropathogens (1981) (0)
Comparative Proteomic Analysis of Enterohemorrhagic E. coli (EHEC) Grown In Vitro Versus In Vivo using a 2-DE Gel Approach. (2010) (0)
A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits (2022) (0)
Hafniaalvei, a Probable CauseofDiarrhea inHumans (1991) (0)
148. Variable fragment of heavy chain antibody (VHH)–based neutralizing agents (VNAs) as unconventional and versatile therapeutics for toxin-mediated diseases (2015) (0)
An SIV-Infected Macaque Model of Enterocytozoon bieneusi Infection. (2022) (0)
Introduction to Cryptosporidum Parvum (1998) (0)
Cultivation andCharacterization ofNovelHumanGroupA Rotaviruses withLongRNA Electropherotypes, Subgroup II Specificities, andSerotype 2VP7Genes (1991) (0)
Cryopreservation of infectious cryptosporidium parvum oocysts achieved through vitrification using high aspect ratio devices (2020) (0)
A Chimeric Vaccine Prevents Primary and Recurrent Clostridium difficile Infection (2011) (0)
piglet as a model of human infection . enteritis : evaluation of the gnotobiotic Enteropathogenic Escherichia coli and (2006) (0)
Traditional enteropathogenic Escherichia coli serotypes demonstrate aplasmid-mediated localized adherence incultured HeLaorHEp-2cells andinduce anattaching-effacing (1991) (0)
Cryptosporidium: another gut pathogen? (1986) (0)
Innovative methods for non-invasive delivery of vaccines/therapuertics to combat infant and childhood diarrheal diseases (2015) (0)
Transcriptome analysis of pig intestinal cell monolayers infected with Cryptosporidium parvum asexual stages (2018) (0)
Advances in Parasitology, Vol. 27@@@Exoerythrocytic Development of Malarial Parasites@@@Cryptosporidosis in Perspective@@@Parasites and Complement@@@Chemical Communication in Helminths@@@The Nature, Extent and Significance of Variation within the Genus Echinococcus (1989) (0)
Data for: An Immunocompetent Rat Model of Infection with Cryptosporidium species, hominis and parvum (2019) (0)
, Infection Primary and Recurrent Clostridium difficile A Chimeric Toxin Vaccine Protects against (2012) (0)
Pregnant sows immunized with Cryptosporidium parvum significantly reduced infection in newborn piglets challenged with C. parvum but not with C. hominis (2022) (0)
The transcriptome of Cryptosporidium oocysts and intracellular stages (2019) (0)
Sa.121. Cytokine Responses Following Infection of Shigella Dysenteriae Type 1 in Gnotobiotic Piglet Model (2008) (0)
Stx 2 Variants Expressing Escherichia coli Infection with Antibodies Protect Mice against Lethal Stx 2-Specific Human Monoclonal (2003) (0)
The impact of Actotoxumab treatment of gnotobiotic piglets infected with different Clostridium difficile isogenic mutants. (2020) (0)
Economically significant enteric infections in domestic animals in Australia (1988) (0)
RNA Gel Electrophoresis: A Technique to Monitor Laboratory Cross-Contaminations and Genetic Reassortment Amongst Rotavirus Isolates (1981) (0)
Peripheral blood granulocytes and mononuclear cell responses in monkeys with experimental shigellosis. (1994) (0)

This paper list is powered by the following services:

Other Resources About Saul Tzipori

en.wikipedia.org

What Schools Are Affiliated With Saul Tzipori?

Saul Tzipori is affiliated with the following schools: